Arcellx (ACLX) Other Non-Current Assets (2021 - 2025)

Arcellx's (ACLX) quarterly Other Non-Current Assets came in at $3.0 million in Q4 2025, up 179.29% year-on-year from $1.1 million in Q4 2024, and up 14.98% quarter-over-quarter from $2.6 million in Q3 2025.

Arcellx (ACLX) Other Non-Current Assets (2021 - 2025) Analysis & Trends

Arcellx's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $3.0 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 179.29% year-over-year to $3.0 million in Q4 2025; TTM through Dec 2025 was $3.0 million, a 179.29% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 179.29% from the prior year.
  • Other Non-Current Assets climbed to $3.0 million in Q4 2025 per ACLX's latest filing, from $2.6 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $9.4 million in Q1 2022 and bottomed at $199000.0 in Q4 2021.
  • The 5-year median for Other Non-Current Assets is $2.5 million (2022), against an average of $3.1 million.
  • Across the five-year window, Other Non-Current Assets surged 2192.96% in 2022 and plunged 83.26% in 2024, its largest moves.
  • Year by year, Other Non-Current Assets stood at $199000.0 in 2021, then jumped by 2192.96% to $4.6 million in 2022, then plunged by 47.01% to $2.4 million in 2023, then sank by 55.46% to $1.1 million in 2024, then surged by 179.29% to $3.0 million in 2025.
  • Per Business Quant, the three latest ACLX Other Non-Current Assets figures stand at $3.0 million (Q4 2025), $2.6 million (Q3 2025), and $2.4 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 3.01 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.01 Mn
Sep 30, 2025 2.62 Mn
Jun 30, 2025 2.42 Mn
Mar 31, 2025 2.42 Mn
Dec 31, 2024 1.08 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 2.42 Mn
Mar 31, 2024 2.63 Mn
Dec 31, 2023 2.42 Mn
Sep 30, 2023 7.95 Mn
Jun 30, 2023 2.50 Mn
Mar 31, 2023 2.50 Mn
Dec 31, 2022 4.56 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.50 Mn
Mar 31, 2022 9.40 Mn
Dec 31, 2021 199,000.00